Agilent Technologies Inc.

Agilent Technologies Inc. Division supplies analytical laboratory instruments, immunohistochemistry staining systems, reagents, and laboratory equipment maintenance to federal health and defense agencies as a prime contractor, competing exclusively under full and open procurement with no set-aside participation. The division is a child entity of Agilent Technologies, Inc., a for-profit manufacturer of analytical instruments headquartered in Santa Clara, California; the division itself operates from Carpinteria, California.

The customer base is heavily concentrated in the Department of Veterans Affairs and defense health networks. The top five funding entities by combined potential value—the Department of the Navy Bureau of Medicine and Surgery ($12.6 million across 18 awards), the Defense Health Agency ($8.7 million across 15 awards), and three VA Veterans Integrated Service Networks (VISN 10, VISN 1, and VISN 15 combined totaling $7.8 million across 48 awards)—account for 86 percent of combined potential value across 135 prime awards. By award count, the concentration is tighter: VISN 10 leads with 23 awards, followed by VISN 2 with 20 awards and the Navy Bureau of Medicine and Surgery with 18 awards, together representing 67 percent of the award portfolio. The divergence signals that the Navy and Defense Health Agency anchor the largest individual procurements, while the VA regional networks drive volume through smaller, recurring orders.

Representative work spans three capability domains. Agilent holds a $749,000 indefinite-delivery contract with VISN 10 for immunohistochemical staining systems through May 2028, which has generated four five-year delivery orders ($72,000 in 2023, $111,240 in 2024, $152,769.60 in 2025, and $157,352.64 in 2026) for IHC slide stainers. The Defense Health Agency awarded a $913,640.40 purchase order in September 2025 for a fully automated IHC staining system with dual-platform capacity and integration into the Military Healthcare System Genesis platform at Fort Liberty, North Carolina, completing September 2026. The Navy Bureau of Medicine and Surgery awarded an $11.6 million definitive contract in September 2022 for chromatography maintenance services at Fort Meade and Dover, extending through August 2027. Agilent also supplies specialized reagents, histology consumables, and cancer testing supplies; a recent $249,780.40 Defense Health Agency purchase order (awarded May 2023, completed March 2024) was for cancer reagents supporting laboratory operations.

Agilent's top parent vehicles are single-award and BPA-based indefinite-delivery contracts. Five IDCs represent the visible vehicle footprint: an unnamed Navy-issued IDC (N6264514D5042) has generated 14 task orders totaling $347 thousand; three VA VISN-issued IDCs under different regional networks (36C24120D0004, 36C24220D0036, and 36C25019D0018) have generated 15 task orders totaling $849 thousand combined; and a VA BPA (36C25519A0053) has generated 5 task orders totaling $319 thousand. These vehicles are not government-wide GWACs but single-award regional contracts, indicating Agilent's positioning as a sole-source or preferred supplier within specific VA networks and Defense Health Agency procurement chains.

Activity declined from 2022 (11 awards) through 2026 (1 award to date), dropping from double-digit annual volume to single digits. Five awards—combined potential value $12.8 million—face ultimate completion inside the next twenty-four months, creating recompete exposure on recurring VA stainer and reagent contracts. Agilent carries no subcontract footprint; all 135 awards in the source are prime work, reflecting the division's direct vendor relationship with federal health agencies rather than a teaming or subordinate supply role.

NAICS and PSC categorization reflects the analytical-instrumentation and consumables focus: 60 awards fall under Analytical Laboratory Instrument Manufacturing (NAICS 333516), 45 under In-Vitro Diagnostic Substance Manufacturing (NAICS 325413), and 19 under equipment rental and leasing. By PSC, Laboratory Equipment and Supplies (52 awards) and In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (36 awards) dominate, followed by Medical and Surgical Instruments, Equipment, and Supplies (23 awards) and Chemical Analysis Instruments (8 awards).